Teva launches generic treatment for kidney disease

Teva is the first company to produce generic Zemplar (paricalcitol) tablets in the US. The treatment is for patients with Stage 3 or Stage 4 chronic kidney disease and in Stage 5 patients on dialysis.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.